Krehlik Carrie 4
4 · Global Blood Therapeutics, Inc. · Filed Sep 6, 2022
Insider Transaction Report
Form 4
Krehlik Carrie
Chief Human Resources Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-09-01−8,060→ 24,180 total→ Common Stock (8,060 underlying) - Exercise/Conversion
Common Stock
2022-09-01+8,060→ 8,060 total - Exercise/Conversion
Common Stock
2022-09-01+2,208→ 10,268 total - Tax Payment
Common Stock
2022-09-01$68.15/sh−3,552$242,069→ 6,716 total - Exercise/Conversion
Restricted Stock Units
2022-09-01−2,208→ 15,460 total→ Common Stock (2,208 underlying)
Footnotes (4)
- [F1]Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
- [F2]Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 10,268 shares of Common Stock underlying the Reporting Person's RSUs.
- [F3]The RSUs vest with respect to 25% of the underlying shares on September 1, 2022 and in 6 semi-annual installments thereafter, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
- [F4]The shares of Common Stock underlying the RSUs vest in 8 equal semi-annual installments over 4 years from March 1, 2022, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.